Protein kinase C (PKC) has been proposed as a primary cellular mediator of ischemic preconditioning. However, the role of PKC in eliciting cardioprotection remains controversial. In this review, we summarize the evidence for and against the 'PKC hypothesis' of preconditioning, discuss the important technical limitations currently hampering PKC research, and suggest new approaches (i.e. PKC isoform-specific biochemical assays combined with immunoblotting techniques) that might aid in the definite resolution of this issue.
Introduction
(Ser / Thr) residues in various protein substrates, and this process is considered to be a fundamental regulatory Ischemic preconditioning is a phenomenon of endogenmechanism involved in cellular growth, differentiation and ous protection that renders the heart resistant to sustained immediate regulation of effector functions [14] [15] [16] [17] . One of ischemia [1] [2] [3] [4] [5] [6] [7] . It is generally accepted that this protection the most important roles of PKC is the activation of is a receptor-mediated process, and is realized via signal transcription. During PKC-mediated activation of trantransduction pathways.
scription, constituents of the immediate early gene pro-A signaling factor proposed to be integral in ischemic gram expression (i.e. c-fos and c-jun) form a heterodimeric preconditioning is protein kinase C (PKC) [8] [9] [10] [11] [12] [13] . Our activator protein-1 complex (AP-1) which binds to the objective in this review is to summarize the role of PKC in TRE sequence (12-O-tetradecanoylphorbol b-acetate rethe general mechanism of cellular processes in the heart, sponsive element) within the promoter region. It is this discuss the evidence for and against PKC as a mediator of binding to the responsive element that activates gene the cardioprotection achieved with brief preconditioning expression [16] . In cardiomyocytes, direct involvement of ischemia, and provide suggestions as to how the controver-PKC in this process was confirmed for genes expressing sies regarding the role of PKC in preconditioning might be light chain 2 of cardiac myosin, atrial natriuretic factor, 21 resolved. and the cardiac isoform of sarcoplasmic Ca -ATPase [16, [18] [19] [20] . PKC-mediated gene activation also was suggested to be involved in cardiac hypertrophy [17] .
The function of PKC in the heart
PKC has further been implicated in immediate functional regulation of cardiac proteins via their direct phos-PKC catalyzes the transfer of g-terminal phosphate from phorylation. For example, PKC has been reported to ATP to the hydroxyl group of serine and / or threonine catalyze phosphorylation of troponin I and troponin T subunits in bovine cardiac troponin complex [21] . Since this study was conducted by employing isolated cardiac al PKC isoforms (i.e. a, b , b , and g) are more abundant 1 2 proteins, it is not clear whether these in vitro findings are than the novel PKC isoforms [13] . In contrast, in adult dog physiologically relevant. PKC has been identified as a hearts, the two major PKC isoforms are´and z [17], while regulator of heart contractility, yet studies with phorbol in human cardiac tissue, PKCd is the major isoform, and esters (positive modulators of PKC activity) have been the minor isoforms are represented by PKC a,´, z, l and i equivocal. There are reports indicating that phorbol ester [30] . can increase the contractility of isolated adult rat ventricu-
The biological significance of this marked PKC isoform lar myocytes [22] , while other authors, utilizing rat vendiversity among species has not been clarified fully. Only a tricular myocytes and isolated perfused rat hearts, demonfew studies are available indicating isoform selectivity in strated a negative inotropic effect, the latter being conterms of regulating gene expression and substrate modicentration-and time-dependent [23] [24] [25] .
fication. In this regard Kariya et al. reported that PKCb Several recent studies indicate that PKC can modulate preferentially activated the transcription of b-myosin ion currents in cardiomyocytes. PKC activates cardiac heavy chain, while PKCa was only a modest activator of 1 ATP-sensitive K channels, and thus acts as a K its transcription [32] . Isoform-specific substrate modifica-ATP channel opener [26, 27] . Increased PKC association with tion was also confirmed for troponin I and troponin T from 21 ventricular cardiomyocyte membranes also resulted in a bovine troponin complex. PKCd caused a decrease in Ca decreased Ca transient and thus might explain the negative sensitivity of actomyosin Mg-ATPase by phosphorylating i inotropy induced in some studies by phorbol esters [23] .
Ser-23 / Ser-24 residues in troponin I molecules. PKCz, on Despite ongoing controversies, these studies clearly the other hand, was shown to be unique in its selective reveal that PKC can be involved in several important phosphorylation of specific sites in the troponin T mole- 21 mechanisms underlying different types of cellular effects. cule and in causing an increase in actomyosin Ca PKC-mediated effects on contractile proteins and ion sensitivity [21] . channels may underlie immediate responses to physiological and / or pathological stimuli, while participation in the regulation of the genome may indicate its involvement in such fundamental cellular processes as growth and dif-4. The concept of PKC translocation ferentiation.
Under baseline conditions, PKC is rendered largely inactive by intramolecular interaction between 'pseudo-3. Cardiac PKC isoforms in different species susbstrate' and catalytic sites. Pseudosubstrate represents a part of the structure of PKC that interacts with its active The PKC family consists of 12 closely related Ser / Tre site and causes PKC autoinhibition. PKC activation kinases, classified into three distinctive subfamilies. The weakens conformational interactions between the pseudosubfamily of conventional, or classical PKC isoforms, substrate and the catalytic sites, and makes the pseudoincludes PKC a, b , b and g isoforms, and requires both susbstrate sequences less accessible to the PKC catalytic 1 2 calcium ions and lipids (i.e. phosphatidylserine, PMA moiety [33] . and / or diacylglycerol) for their activation. The subfamily Calcium-dependent PKC isoforms from various tissues of novel PKC isoforms, which includes PKC d,´, h, u and have been shown to be stimulated by diacylglycerol, in the m, does not require calcium, but, as with the classical presence of calcium ions and phospholipids (e.g. phosphaisoforms, still requires lipids for their activation. The tidylinositol, phosphatidylserine and phosphatidic acid). subfamily of atypical PKC isoforms includes PKC z, i, and Diacylglycerol, containing unsaturated fatty acids, was l. PKCz requires phosphatidylserine for its activity, but identified as the most active constituent, capable of enneither calcium ions, nor diacylglycerol and / or PMA are hancing the phospholipid-dependent PKC activation needed for its activation. [34, 35] . By 1980 it was known that phosphatidylinositol is In adult rat hearts, novel PKC´and d are the major one of the most rapidly metabolized cellular phospholipids isoforms. Minor PKC isoforms are represented by novel in response to various extracellular messengers, is mainly PKCh and atypical PKC i and z [11, [28] [29] [30] . Conventional composed of unsaturated fatty acids, and diacylglycerol is calcium-dependent PKC isoforms represent only a very one of its first turnover products. Based on these facts it small portion of all PKC expressed in the adult rat heart, was suggested that phospholipase C-mediated cleavage of and are believed to originate from cellular elements other phosphatidylinositol may be crucial for PKC activation than myocytes [29] . In adult rabbit hearts, immunoblotting [35] . Tumor-promoting phorbol ester (i.e. 12-O-tetraderevealed the presence of conventional PKCa, PKCb , canoylphorbol 13-acetate, TPA) was also able to activate 1 21 PKCb and PKCg, novel PKC´and atypical PKCz [31] . Ca -dependent PKC directly and to increase PKC affinity 2
In a recently published study 10 individual PKC isoforms for calcium ions significantly [36] . In parietal yolk sac were found in rabbit heart; i.e. PKC a, b , b , g, d,´, z, h, (PYS) cells TPA was able to increase dramatically the panied by its decrease in the cytosol [37] . Similarly, 5. Measurement of PKC activity and its subcellular diacylglycerol also was shown to promote PKC association distribution with the membrane fraction of PYS and NIH 3T3 cells [38] . More recent studies have reported that diacylglycerol
The unusual properties of PKC (i.e. its translocation to significantly increases PKC binding to phosphatidylcholdifferent subcellular compartments upon activation) comine / phosphatidylserine-containing membranes with high plicates the quantitative assessment of this enzyme. For selectivity towards the phosphatidyl-L-serine moiety example, the assay cannot be performed in whole tissue [39, 40] . A cysteine-rich region within PKC regulatory homogenates; rather, subcellular fractionation is mandatdomain was implicated in the diacylglycerol-and phorbol ory. During subcellular fractionation, possible cross-conester-dependent regulation of PKC activity and its subceltamination between subcellular compartments deserves lular distribution [41] [42] [43] . As a result of all the aboveserious consideration. In this regard, a detailed characterimentioned studies, the concept of PKC translocation was zation of isolated fractions by electron microscopy and / or formulated.
measurement of marker enzymes is necessary. Finally, the PKC activation and subsequent translocation to memfact that there are 12 individual PKC isoforms may result brane compartments is a key event in the PKC-dependent in the requirement of performing isoform-specific measuresignaling cascade, and is preceded by agonist-mediated ment of PKC activity. stimulation of receptor-associated phospholipase C (PLC).
Most of the radioactive PKC assay methods are based PLC, upon stimulation, cleaves inositol-1,4,5-trisphosphate on the incubation of isolated subcellular fractions with 32 and diacylglycerol from the membrane-bound phosg-P-ATP in the presence of PKC specific substrate. (Table 2) . As a result, specific proteins within the membrane and nuclear subcelthere is a danger that activation and / or translocation of a lular fractions. Intracellular receptors for activated PKC minor PKC isoform may not be detected. There are several (RACK proteins; i.e. receptors for activated C-kinase) peptides that can successfully distinguish activities of have been described, and some of them were successfully conventional plus novel PKC isoforms (i.e. EGF-derived cloned [45] [46] [47] . Their ability to interact specifically with peptide and MBP-derived peptide), and activities of PKCṔ KC molecules was tested in experiments in which and a (PKC´pseudosusbstrate-derived peptide), but none purified rat brain RACKs, injected into Xenopus oocytes, of them allows the specific determination of activities of competed for PKC with endogenous RACKs and inhibited individual PKC isoforms present in a particular species, the maturation of oocytes [48] . The discovery of PKCtissue and / or subcellular compartment. However, it may anchoring proteins is a significant step toward our underbe possible to develop this kind of technique. Isoformstanding of the complexity of the PKC-mediated signaling specific antibodies to all PKC isoforms detected in rat and cascade, and may provide an explanation of how different rabbit hearts are currently available. Thus, by making PKC isoforms are translocated to different subcellular corresponding combinations of PKC-specific antibodies compartments.
and PKC substrates, it should be possible to prepare a PKC translocation has been documented for many reaction mixture which will detect only one PKC isoform, conventional, novel and atypical PKC isoforms in the while all other isoforms present in the sample of interest heart, but its biological significance is still far from being will remain blocked by their antibodies. If developed, this resolved. The recent discovery of RACK proteins may method could become a very useful tool in PKC-related provide additional support for the PKC translocation studies. concept. These proteins may work in concert with the PKC PKC immunoblotting represents a valuable alternative to activation process both by directing activated PKC molebiochemical assessments, and has been successfully emcules to specific subcellular compartments and stabilizing ployed by numerous laboratories worldwide. This techtheir active state within these particular compartments.
nique utilizes electrical current to isolate proteins present However, despite the fact that the translocation of PKC is in processed tissue samples and / or subcellular fractions, considered a key step in PKC-mediated signaling, PKC and to transfer them (i.e. to blot) to nitrocellulose filter, or activation, not followed by its translocation, cannot be nylon membrane. Nonspecific sites of blotted proteins are ruled out.
blocked with milk proteins, and primary antibodies against Fig. 1 . Subcellular distribution of protein kinase C (PKC) activity measured in rabbit heart using a radioisotope-based biochemical method (Amersham PKC assay kit). In the in vivo model of coronary artery occlusion (Panel A), PKC activity in the cytosolic (data not shown for simplicity) and particulate fraction (containing nuclei and membranes) was comparable in both nonischemic control hearts and hearts that received 2 5-min episodes of preconditioning (PC) ischemia. That is, there was no evidence of PKC translocation to the particulate fraction in response to brief, in vivo regional ischemia. Adapted from reference [56] . In contrast (Panel B), in the excised rabbit heart, PKC activity in the membrane and nuclear compartments was increased following only 2 min of normothermic global ischemia when compared with matched baseline samples. Adapted from reference [103] .
individual PKC isoforms are added. After incubation and Heights, IL). This technique provides the investigator with washing, all proteins blotted and tagged with primary information regarding the presence and location of inantibody are incubated with secondary horseradish perdividual PKC isoforms, but does not determine its activity oxidase-tagged antibody, allowing the investigator to perstatus. Since the association with membranes does not form qualitative and / or semiquantitative analysis of the necessarily reflect the state of activation, the lack of PKC immunological reaction between individual PKC isoforms activity data is an important limitation of immunoblotting and the primary antibody. The bound antibody can be technique [15] . detected by reading the luminescence produced after the The activity and subcellular distribution of PKC has also oxidation of luminol by horseradish peroxidase (ECL been studied in isolated cells and frozen tissue samples by Immunoassay Signal Reagent, Amersham, Arlington labeling PKC with cell-permeable fluorescent probes (e.g. PKC inhibitor bisindolylmaleimide conjugated to fluoresinhibitors in vivo, by utilizing differences in surface cein): [49, 50] . Although not isoform-specific, this approach receptors and / or other cell-specific markers. has the unique advantage that the fluorescent probe binds to the catalytic domain of PKC and thus is selective for active enzyme [49, 51] . Since there are numerous PKC 6. PKC and ischemic preconditioning inhibitors with different isoform specificity, this method may represent an attractive alternative to the above-menDespite almost ten years of intensive study, the cellular tioned immunoblotting technique. mechanism responsible for preconditioning still remains Another important issue is the cellular origin of PKC obscure. One of the most popular hypotheses implicates isoforms found in the heart: i.e., without knowing whether the translocation of PKC from the cytosol to the sarcolemthe PKC isoforms are present in myocytes, endothelial ma and subsequent phosphorylation of an as-yet unknown cells, etc., it is difficult to determine whether changes in protein target as key events in achieving cardioprotection. activity and / or subcellular distribution are relevant to A large body of experimental data, largely based on myocardial ischemia, and represent specific changes within indirect pharmacological evidence, has supported the 'PKC the cardiomyocytes. For example, Ping and colleagues hypothesis' of preconditioning [8, 9, 54] . However, direct recently reported the presence of 10 individual PKC measurements of the subcellular distribution of PKC have isoforms in adult rabbit heart [13] . However, without the failed to conclusively demonstrate its involvement in the information regarding their cellular location it is not clear protective effect of ischemic preconditioning [49, 55, 56] . whether changes in the subcellular distribution of PKC The role of PKC in preconditioning has been studied in isoforms are taking place solely in cardiomyocytes.
rats, rabbits, dogs and swine, both in vivo and in vitro, Thus, in summary, we at present do not have a reliable utilizing different experimental models and preconditionand quantitative method capable of determining the activiing protocols. In this section, we review the current ty and subcellular localization of specific isoforms of PKC.
controversies regarding the involvement of PKC in acute To address this problem, an isoform-specific immunoprotection elicited by intermittent brief episodes of isblotting technique needs to be combined with a biochemichemia and reperfusion (i.e., so-called 'classical' precondical isoform-specific assay. The latter can be developed by tioning). employing isoform-specific antibodies and already existing PKC activity assay methods. Combination of immunoblotting technique with this prospective biochemical meth-7. Studies in rabbits od may overcome limitations of currently available PKC assay systems. Alternatively, Johnson and colleagues
The PKC hypothesis of ischemic preconditioning was recently introduced a PKC-specific peptide and isoformfirst formulated by Downey and colleagues using the rabbit selective PKC translocation inhibitor into cultured neonatal model. Specifically, Ytrehus et al. demonstrated that either cardiac cells [52, 53] . This technique lays the groundwork staurosporine and polymyxin B, when given in vivo 5 min for selective labeling of myocardial and non-myocardial before a 30 min sustained occlusion (i.e. midway during cells with PKC specific substrates and / or translocation the 10 min period of intervening reflow), were able to 30 min ischemia) only partially blocked the protective that staurosporine, administered 5 min before the precondieffect of ischemic preconditioning induced by one cycle of tioning episode, did not abolish the protective effect of intermittent ischemia / reperfusion, and did not affect ischemic preconditioning. However, when microtubules protection induced by three cycles. These results indicate within the cardiomyocytes were purportedly disrupted with that PKC activation, while contributing to myocardial colchicine, the protective effect of ischemic preconditionprotection in the one-cycle model, is not a prerequisite in ing was blocked [9] . Based on their observations, the the three-cycles preconditioning model, and implicates the authors concluded that PKC activity is not required during participation of other factors [57] . The one-cycle data the preconditioning episodes, and the integrity of the presented by Sandhu et al. does not support the previous membrane compartment is crucial for the protection afobservation that polymyxin B completely abolishes the forded by ischemic preconditioning. According to their protective effect of ischemic preconditioning [8] . The hypothesis, preconditioning ischemia causes PKC translodifference in the doses of polymyxin B in studies with cation into the membrane compartment, facilitating phospartial versus complete loss of protection does not appear phorylation of an as-yet unknown protein target during to explain the discrepancy, since in the study with partial sustained ischemia. Importantly, however, neither PKC inhibition the dose of polymyxin B, selected based on its translocation, nor the disruption of microtubules by colvolume of distribution, was reportedly capable of inhibchicine, were confirmed directly.
iting more than 90% of PKC present in the heart [57] . In a recently published paper Downey's group expanded Using the in vivo rabbit model, our laboratory tested the upon their initial observation. Using isolated perfused PKC hypothesis of ischemic preconditioning by directly rabbit hearts subjected to brief global preconditioning measuring the subcellular distribution of PKC in control, ischemia and sustained regional coronary occlusion, they preconditioned and sham operated hearts [56] . The prereported that staurosporine blocked the protective effect of conditioning stimulus consisted of two 5 min episodes of ischemic preconditioning only when it was present in the transient regional ischemia each separated by 5 min of perfusion medium following the episode of preconditionreperfusion. Samples were obtained immediately after the ing ischemia (i.e. during the intervening reperfusion) and preconditioning protocol, or after 10 min into what would during the early phase of sustained occlusion. In contrast, be the sustained ischemic insult. PKC was assayed in the protective effect of ischemic preconditioning was still cytosolic, nuclear and membrane fractions using a radiopresent when the PKC inhibitor was added before preisotope-based biochemical technique. There was no differconditioning ischemia / reperfusion, but washed out before ence in the subcellular distribution of PKC in hearts the sustained occlusion [54] . Based on their results the sampled immediately after the last episode of preconditionauthors concluded that ischemic preconditioning is a twoing ischemia / reperfusion when compared with timephase phenomenon. The first phase serves as a trigger, matched (nonischemic) controls (Fig. 1A) . By 10 min into does not require PKC-mediated phosphorylation, and only what would be sustained ischemia, there was a strong trend involves PKC translocation. This phase occurs during the toward PKC translocation to the nuclear and the membrane preconditioning stimulus, and is not blocked by staurosfractions in both non-preconditioned controls and preporine. During the second (mediation) phase, PKC-meconditioned groups versus nonischenic sham-operated rabdiated phosphorylation is mandatory; this phase occurs bits. Importantly, however, no difference in the subcellular during the early period of sustained occlusion, and is profile of PKC was observed in time-matched groups of blocked by staurosporine. preconditioned vs. non-preconditioned hearts. In other This concept has not, however, been confirmed by all words, we failed to demonstrate PKC translocation with 5 laboratories studying the role of PKC in ischemic premin of intermittent preconditioning but, with a more conditioning. For example, Mitchell and colleagues in the prolonged (i.e. 10 min) sustained ischemic insult PKC does rat model (to be discussed in detail later) abolished the begin to redistribute from the cytosol into the particulate protective effect of ischemic preconditioning even when compartment. Our results are in good agreement with the staurosporine was given prior to the preconditioning observations of Pongo and colleagues, indicating that in ischemia and washed out before the sustained ischemic isolated rabbit heart only sustained occlusion of 20 min insult [11] . Thus, even if PKC is believed to play a role, duration resulted in a significant PKC translocation from there is disagreement regarding the timing of PKC activathe cytosol into the membranes compartment. A precondition. The fact that Yang et al. [53] and Mitchell et al. [11] tioning protocol (i.e. three episodes of ischemia each performed their studies in different species may be an separated by 5 min of reperfusion) did not induce PKC explanation for these discrepancies. On the other hand, it is translocation: rather, an opposite effect (a decrease in its somewhat hard to believe that such a fundamental protecactivity) was observed in both the cytosol and the mem- branes. The authors concluded that, in contrast to the PKC contracture and loss of viability in isolated cardiomyocytes hypothesis, decreased, rather than increased PKC activity during simulated sustained ischemia, thus mimicking the might be a factor contributing to the protection rendered by protective effect of ischemic preconditioning [68] . This ischemic preconditioning [58] . Lasley et al. came to the observation indicates that manipulations downstream of same conclusion, when they observed that the PKC PKC (i.e. modification of protein structure) may play an inhibitor bisindolylmaleimide significantly reduced infarct important role in cardiac protection. size in pentobarbital anesthetized rabbits subjected to 45 min of sustained ischemia [59] .
Ping and colleagues employed both a biochemical 8. Studies in rats isoform-nonspecific assay for PKC and an immunoblotting technique. The authors detected ten PKC isoforms in adult Speechly-Dick and colleagues showed that in the in vivo rabbit heart. Using the isoform-nonspecific biochemical ischemia model, the PKC inhibitor chelerythrine, adminisassay, they found no evidence of PKC translocation tered after a preconditioning stimulus (i.e. prior to susfollowing classic in vivo preconditioning. However, when tained ischemia), abolished protection conferred by isimmunoblotting was applied, the authors noticed translocachemic preconditioning, and caused an increase in infarct tion of PKC´and h [13]. As discussed previously, this size. In the same study the PKC stimulator 1,2-dioctanoylobservation is tempered by the question of whether these sn-glycerol, also administered prior to sustained ischemia, isoform-selective changes in the subcellular distribution of significantly reduced infarct size. Chelerythrine and the PKC occurred in myocytes or other cardiac cells. In vehicle DMSO had no effect in non-preconditioned rats addition, the authors did not separate the particulate
[10]. Similar results from our laboratory indicated that fraction into nuclear vs. membrane components, so the another PKC inhibitor -calphostin C -also abolished the precise site of translocation is not clear.
protective effect of ischemic preconditioning and increased Since ischemic preconditioning is a receptor-operated infarct size compared to preconditioned animals. In this phenomenon, involving, in the rabbit model, both adenostudy, the PKC inhibitor was administered twice; i.e. sine A -and a-adrenoreceptors, several laboratories before preconditioning ischemia, and 3 min before the 1 attempted to mimic preconditioning by stimulating these onset of sustained coronary occlusion [69] . Thus, regardreceptors. Adenosine and its analogues showed a clear less whether or not PKC inhibitors were present during the protective effect against sustained ischemic insult, while its preconditioning stimulus, administration prior to sustained antagonists increased the infarct size and / or abolished the ischemia abolished the protective effect of ischemic preprotective effect of ischemic preconditioning [4, [60] [61] [62] .
conditioning. These studies may be considered as positive a-Adrenergic agonists (i.e. norepinephrine and phenylepor consistent with the 'PKC hypothesis' of preconditionhrine) were also capable of inducing protection in the same ing. However, no direct measurements of PKC activity ischemia model [63] [64] [65] . The protective effect of and / or subcellular distribution were performed. Whether phenylephrine was blocked by both polymyxin B and the the effects of these particular pharmacological agents are adenosine receptor blocker 8-( p-sulfophenyl)theophylline.
solely attributed to PKC, or are due to other as-yet Based on these observations it was suggested that pharmaunknown effects, remains unanswered. For example Li and cological preconditioning is relevant to its classical isKloner reported partial inhibition of preconditioning in the chemic version, and PKC activation represents a key event rat model with nonspecific PKC blocker H-7, also known [63, 66] . However, no PKC activity measurements were to inhibit PKA and PKG [70, 71] . performed in most of these studies, and this conclusion is Confirmatory results have been reported in the isolated solely based on indirect, isoform non-specific pharmacorat heart model of regional ischemia: Bugge and Ytrehus logic studies.
found that the PKC antagonists polymyxin B and The original 'PKC hypothesis' implies that phosphorylachelerythrine blocked the protective effect of ischemic tion of a target protein following PKC activation is an preconditioning [72] . The authors also attributed these important step in rendering the heart resistant to sustained effects to protein kinase C inhibition, but, unfortunately, ischemic insult. Although PKC substrates are poorly no measurements of PKC activity and / or subcellular characterized, it is known that these enzymes phosphordistribution were performed. ylate proteins containing the sequence X-Arg-X-X-Ser / A large body of data, both supporting and contradicting Thr-X-Arg-X [14]. Targets may include myofibrillar prothe PKC hypothesis, has been obtained in the isolated rat teins, ion channels and MARCKS (myristoylated alanineheart subjected to sustained global ischemia. In this model, rich C kinase substrate) [67] . Given this list of PKC functional recovery during reperfusion is typically chosen substrates, one may suggest that changes in their structure as the index of damage caused to the heart by sustained (i.e. phosphorylation / dephosphorylation) may have signifiischemia, and to evaluate the protective effect of ischemic cant impact on cardiac cells. In fact, Armstrong et al. PKC theory, while those seen with 800 nM supported the glycerol analogue 1-stearoyl-2-arachidonoyl glycerol concept [75] . mimicked the benefits of ischemic preconditioning. MoreIn a study performed by Chen and colleagues, ischemic over, immunoblotting for PKC isoforms showed that the preconditioning with four cycles of 5 min ischemia / retwo major isoforms in rat heart, PKCd and PKC´, both perfusion significantly improved postischemic functional translocated during brief episodes of transient ischemia recovery of the isolated rat heart. Functional recovery was from the cytosol into the membrane and the nuclear also improved by dioctanoyl glycerol but not by PMA compartments [11] . The authors also suggested that PKC [76] . Thus, as both agents can induce PKC translocation, translocation upon transient ischemia is labile and can be these results raise doubts as to whether subcellular redistrireversed. This seems to be an attractive addition to the bution of PKC is protective. On the other hand, 'PKC hypothesis', since constitutive PKC upregulation chelerythrine abolished the protective effect of ischemic may cause so-called 'PKC syndrome' (i.e. hypertension, preconditioning and blocked functional improvement inatherogenesis, hypercoagulability, insulin resistance, and duced by dioctanoyl glycerol, results that fit the PKC cancer promotion) [73] .
hypothesis. Inconclusive results were also obtained in In a study performed by Hu and Nattel two 5 min isolated rat hearts subjected to hypoxia and low-flow periods of ischemia followed by 10 min of reperfusion ischemia. Brief episodes of hypoxic perfusion (10% of preserved LV developed pressure following 30 min of control values) protected isolated rat hearts from sustained global ischemia. Pretreatment with PKC inhibitors H-7 and no-flow ischemic insult [77] . However, polymyxin B did bisindolylmaleimide blocked ischemic preconditioning, not alter functional recovery of non-preconditioned hearts while the PKC activator PMA mimicked its protective subjected to more prolonged low-flow ischemic stimulus effect. Based on their results, the authors concluded that [78] . These results indicate that PKC activation and / or PKC stimulation renders the heart resistant to a later translocation (if any) during low-flow ischemia does not sustained ischemic insult [74] .
underlie the protective effect achieved with brief episodes Other results using this model have, however, been of hypoxic perfusion, and thus imply that PKC is not the inconclusive. Tosaki et al. reported that ischemic precondisole mediator of this phenomenon. tioning decreased the incidence of reperfuson arrhythmias, While several of the above mentioned studies may be and the PKC inhibitor calphostin C, in doses of 200 and considered as partially 'positive' [75, 76, 78] , 'negative' 400 nM, caused a further decrease in their incidence in results have also been obtained in the same isolated rat preconditioned hearts. Thus, in apparent contrast to the heart global ischemia model. For example, Galananes and 'PKC hypothesis' the protective effect of ischemic precolleagues, using immunoblotting, were not able to demonconditioning was amplified by the addition of the PKC strate translocation of PKCd and PKC´in the isolated rat inhibitor. Interestingly, however, the attenuation of the heart preconditioned with two brief cycles of ischemia and protective effect of ischemic preconditioning was observed reperfusion [55] . Recently Moolman and colleagues rewhen a very high dose of calphostin C (i.e. 800 nM) was ported that PKC inhibitors chelerythrine (10 mM) and employed. A similar biphasic, dose-dependent pattern was bisindolylmaleimide (4 mM), given either during the seen with recovery of left ventricular pressure. Although preconditioning protocol or before the onset of sustained the authors found no protection with preconditioning per se ischemia, did not abolish the protective effect of ischemic upon recovery of left ventricular function, addition of preconditioning in globally ischemic rat heart. Moreover, calphostin C in the concentration of 200-3400 nM augthe PKC inhibitors were also unable to block the reduction mented, while a concentration of 800 nM inhibited, in lactate accumulation caused by ischemic preconditionpostischemic functional recovery [75] .
ing [79] . Thus, the conclusion reached by these latter In this study, physiologic measurements were accomstudies is that PKC may not be involved in the mechanism panied by direct biochemical assessment of PKC activity of ischemic preconditioning. and its subcellular distribution using the Amersham PKC Several receptors have been implicated in the mechaassay kit. Four cycles of preconditioning ischemia resulted nism of ischemic preconditioning in rat model. Mitchell et in an increase in PKC activity in both cytosolic and al. reported that stimulation of a-adrenergic receptors with particulate compartments to the same extent. This is a phenylephrine can induce myocardial protection in isolated surprising finding, since the original PKC theory predicts rat heart, which can be blocked by PKC antagonists (i.e. only PKC translocation (i.e. redistribution of its activity) staurosporine and chelerythrine). They also reported that rather than a net increase in total amount and / or activity in phenylephrine caused translocation of PKCd to the sarresponse to brief ischemia. The authors further reported colemma, and suggested that translocation of this PKC that all concentrations of calphostin C inhibited PKC in a isoform is a significant step in preconditioning induced by dose-dependent manner. Thus, in the same preparation, a-adrenoagonists caused significant translocation of another PKC isoform, the same canine model, reported that polymyxin B, i.e. PKC´(not PKCd) [80] . These results indicate that administered only before and during the preconditioning a-adrenergic stimulation may trigger translocation of stimulus (not into sustained occlusion), and at a lower different PKC isoforms in vivo vs. in vitro settings.
dose, completely abolished the protective effect of preHowever, Bugge and Ytrehus did not confirm that aconditioning [83] . Contradictory results were also reported adrenoreceptors are involved in cardiac protection, and regarding PKC activity. In both studies the same assay kit reported that blockade of a-adrenoreceptors with phenoxfrom Amersham was employed. In our experiments we ybenzamine did not abolish the protective effect of iswere unable to detect PKC translocation with preconditionchemic preconditioning in the isolated rat heart [72] .
ing. However, Kitakaze et al. observed significant PKC Recently it has been reported that protection induced by translocation with preconditioning. This effect was noticed bradykinin and endothelin-1 in the isolated rat heart model when the assay mixture contained all co-factors; (i.e. lipids was effectively blocked with chelerythrine [81, 82] . Thus, and calcium ions) and thus presumably detected all PKC several endogenously produced factors may be involved in isoforms (conventional, novel and atypical). In contrast, heart protection; however, the exact mechanism, and the when calcium ions were omitted from the system, the required combination of these factors remain unclear.
authors were unable to demonstrate PKC translocation. Based on these results, Kitakaze and colleagues concluded, that only conventional Ca-dependent PKC isoforms are translocated with ischemic preconditioning. In the absence 9. Studies in dogs of calcium Kitakaze et al. further observed a significant decrease in PKC activity in the cytosolic fraction, thereby Studies in dogs have also yielded controversies regardindicating that the majority of PKC in this fraction is ing the involvement of PKC in ischemic preconditioning.
represented by conventional isoforms. In contrast, in our In our studies, four 5 min episodes of transient ischemia, experiments, under the same conditions we did not observe each separated by 5 min of reperfusion, significantly a decrease in PKC activity in the cytosolic fraction, limited infarct size caused by a 1 h sustained coronary suggesting that the majority of PKC in the cytosolic occlusion. Two PKC blockers, H-7 and polymyxin B, fraction is represented by calcium-independent isoforms. infused before and throughout the preconditioning stimulus When both calcium ions and lipids were omitted from the and early into sustained ischemia, were unable to abolish assay mixture, Kitakaze and colleagues reported no statistithe protective effect of ischemic preconditioning. Morecally significant changes in PKC signal in the membrane over, we sought to detect PKC translocation during fraction from the ischemic LAD bed, and their calciumpreconditioning by staining tissue samples with a fluoresand lipid-independent blank comprised |70 to 85% of cent probe specific for active PKC, and by radioisotopewhat was detected when both co-factors were present in based biochemical assay (Amersham PKC Assay Kit).
the assay system. In contrast, in our experiments, calciumWhen fluorescence microscopy technique was applied, we and lipid-independent blanks in the particulate fraction observed no change in the intensity or location of fluoresfrom the LAD bed averaged 7 and 9% of the total PKC cence staining after either one or four 5 min episodes of activity in the control and preconditioned groups respecbrief preconditioning ischemia / reperfusion. Similarly, with tively. the radioisotope-based biochemical technique, we were Our results therefore suggest that the majority of PKC in also unable to detect any change in its subcellular disdog heart is represented by calcium-independent isoforms. tribution in preconditioned vs. control dogs at the end of This is in agreement with Steinberg et al., who reported the preconditioning regimen. When hearts were sampled at that conventional calcium-dependent isoforms are not 10 min into what would be the sustained occlusion, PKC expressed (or expressed at negligible levels) in adult dog activity in the particulate fraction was increased in both heart: rather, only the novel calcium-independent PKCć ontrol and preconditioned groups when compared with and atypical PKCz were clearly detected [17] . Moreover, dogs that received preconditioning or no intervention we failed to observe PKC translocation during the prealone. Importantly, however, there was no difference in the conditioning protocol [49] . Data published by Kitakaze subcellular distribution of PKC between matched control and colleagues indicate that the predominant PKC isoforms and preconditioned hearts sampled at either time point.
in canine heart are calcium-dependent, and these isoforms Our positive control (PMA) did, however, yield the undergo extensive translocation with ischemic precondiexpected activation and redistribution of PKC between tioning [83] . At present, there is no explanation for these cytosolic and particulate fraction with both methods. These discrepancies: further investigation using biochemical isoresults fail to support the hypothesis that PKC translocaform-specific methods would be required to resolve this tion during brief episodes of preconditioning ischemia is issue. an important factor in the mechanism of ischemic preSeveral conflicting results regarding possible implication conditioning in the dog model [49] .
of a-adrenoreceptors have been reported, with no direct In marked contrast to our findings, Kitakaze et al. using proof of any PKC involvement [84, 85] . effectively abolished it. The PKC activator PMA was also and was inhibited by the PKC antagonist calphostin C. The able to abolish the protection induced by ischemic preauthors also performed measurements of PKC activity by conditioning, while, paradoxically, in non-preconditioned in situ phosphorylation of a PKC-specific peptide. PKCanimals, the PKC inhibitor bisindolylmaleimide exerted mediated phosphorylation was increased both with prelocal protection [86] . This study suggests a key role for conditioning, and PMA treatment, and was abolished by adenosine A receptor activation in ischemic preconditioncalphostin C. By employing an isoform-nonspecific 1 ing, and concludes that PKC activation is not involved in fluorescent antibody to PKC, the authors were further able its protective effects in the swine model. In contrast to the to demonstrate an increase in fluorescence in the cell 'PKC hypothesis', these data indicate that PKC inhibition, membranes and in the perinuclear area [94] . As the rather than activation, may protect the heart from a antibody recognizes sequences in the catalytic site of the sustained ischemic insult. Similarly, Vahlhaus and col-PKC molecule, this methods demonstrates that the cataleagues found that, in the pig, staurosporine infused before lytic PKC structure was indeed present, but does not and during brief preconditioning ischemia did not prevent provide information regarding the integrity of the entire the protective effect of ischemic preconditioning, again PKC moiety or the activity status of the enzyme. It is also arguing against the involvement of PKC in preconditioning important to note that the preconditioning stimulus and / or in this model [87] . However, Vahlhaus and colleagues adenosine exposure in the above-mentioned study was of recently provided evidence showing that combined ad-20 min duration. It is well-established that in rat, rabbit ministration of the PKC inhibitor staurosporine and the and dog, 10 min of ischemia causes PKC translocation tyrosine kinase inhibitor genistein abolished the protective [49, 56, 95] . Thus, the changes in PKC activity and / or effect of ischemic preconditioning in the pig, while either subcellular distribution seen with 20 min of anoxia may be agent alone had no effect on preconditioning-induced a secondary phenomenon not directly relevant to precardioprotection [88] . Interpretation of these latter results conditioning-induced protection. may be confounded by the fact that genistein, in addition Several studies have shown pharmacological preconto inhibiting tyrosine kinases, also interferes with the ditioniong of human myocardium. Ikonomides et al. activation of phospholipase C at the G-protein level, and is demonstrated that, in pediatric cardiomyocytes, PKC is a competitive antagonist of adenosine receptors, both translocated following 20 min exposure to adenosine, and factors recognized to be important in 'triggering' the its activity, determined as the in situ phosphorylation of protection achieved with brief antecedent ischemia [89- PKC-specific peptide, is also increased [94]. Cleveland et 91]. Nonetheless, these studies suggest that PKC activation al. reported that in the isolated human trabeculae the is not a prerequisite for preconditioning in swine, and may protective effect of ischemic preconditioning can be implicate the involvement of other protein kinases.
abolished by a-adrenergic blockade and / or PKC inhibition. PKC inhibition with chelerythrine also abolished the protection induced by stimulation of a-adrenoreceptors 11. Studies in humans [96] . Since these protocols were performed in in vitro settings and employed non-traditional preconditioning Speechly-Dick and colleagues subjected human right stimuli, their relevance to in vivo ischemic preconditioning atrial trabeculae to a preconditioning stimulus consisting of is not clear. 3 min of the simulated ischemia (i.e. hypoxic substratefree superfusion combined with pacing at 3 Hz) followed by 7 min of reperfusion, and employed recovery of 12. Current problems in PKC research contractile function after 90 min of simulated ischemia as their end point. Contractile recovery was significantly
The protective phenomenon of classical ischemic preimproved with both preconditioning, and exposure of the conditioning has been unequivocally demonstrated in rats, trabeculae to the PKC activator 1,2-dioctanoyl glycerol, rabbits, dogs and pigs. In contrast, the role of PKC in this when compared with the non-preconditioned group [92] .
protection is controversial in all of these species. ImThe role of PKC in ischemic preconditioning has also portantly, however, based on the available information, we been assessed in cultures of pediatric cardiomyocytes can neither unanimously accept nor completely reject the obtained during surgery from Tetralogy of Fallot patients.
PKC hypothesis. Most of the results in support of the PKC Ischemia was simulated by flushing cultures with 100% hypothesis were obtained using pharmacological approach;
at Pennsylvania State University on February 22, 2013 http://cardiovascres.oxfordjournals.org/ Downloaded from i.e. by administering PKC inhibitors and / or activators. The ischemia, the entire muscle is rendered ischemic, the heart disadvantages of this strategy were recently summarized in is essentially quiescent, and is not exposed to hemoa review published by Brooks and Hearse; almost every dynamic factors. inhibitor has ancillary effects and, for some, their speAs discussed above, we believe there is a need for cificity and selectivity are questionable [97] . A further biochemical, isoform-specific assays. Such assays would limitation of pharmacological studies is that they are allow quantitation of selective PKC isoforms in different isoform-nonspecific. Unfortunately, the same objection is subcellular compartments and, if developed, this method, also applicable to all currently available biochemical combined with immunoblotting, has the potential to betechniques. With regard to isoform specificity, immunocome a valuable tool in PKC studies. We believe it is only blotting is the one approach that can be considered as a through the application of isoform-and cell-specific assays valuable alternative to pharmacological and biochemical that the role of PKC in ischemic preconditioning can be methods. The data provided by immunoblotting is, howconclusively resolved. ever, semiquantitative at best, and provides no information regarding the activity of the PKC isoforms.
Recently Gray et al. successfully employed isoformReferences specific, pharmacological inhibition of PKC. In a cell culture model of hypoxic preconditioning, they found that phorbol ester in this particular model [98] . Isoform-specific tosis-related studies: it was shown that classic and atypical promote apoptosis [99] [100] [101] [102] .
[4] Liu GS, Thornton J, Van Winkle DM, Stanley AWH, Olsson RA,
The role of PKC in ischemic preconditioning has been Downey JM. Protection against infarction afforded by preconditioning is mediated by A adenosine receptors in rabbit heart. Circulaevaluated in a diverse array of models, species and
